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Correlates of Not Using Antiretroviral Therapy
Among Transwomen Living with HIV:
The Unique Role of Personal Competence
Richard A. Crosby,1,2,* Laura F. Salazar,3 and Brandon J. Hill1,4
Abstract
Purpose: This study tested three psychosocial measures for their potential to serve as counseling goals for pro-
moting ART to transgender women living with HIV (TWLH).
Methods: Among 69 TWLH, 17.4% were not taking ART; these volunteers were compared to the remainder
using multivariate regression analyses.
Results: Only onepsychosocialmeasure achieved significance: Personal Competence (AdjustedOdds Ratio = 0.80, 95%
CI = 0.67–0.97, P = 0.02). Because this was a continuous measure, assessed on a 7-point scale, the protective adjusted
odds ratio of 0.80 represents a 20% reduction in the odds of not taking ART for each unit of increase in this construct.
Conclusion: Findings suggest a potential counseling goal for TWLH not taking ART.
Keywords: antiretroviral therapy; counseling; HIV infections; transgender women
Introduction
Although advances in the treatment of HIV/AIDS have
been revolutionary, the full potential of these chemo-
therapeutic agents to reverse the HIV epidemic has
yet to be realized. Latest estimates, for instance, are
that only about 25% of those living with HIV are virally
suppressed.1 A majority of those not taking antiretrovi-
ral therapy (ART) are not engaged in medical care.2–4
Estimates suggest that upwards of 50% of people di-
agnosedwithHIV/AIDS are not in continuous care.5 Fur-
thermore, estimates suggest that 25% of persons who are
engaged in care and eligible for ART are not receiving
this therapy.5 The public health issue of people living
with HIV and not taking ART is one that has been ag-
gressively addressed with empirical studies.6,7 A key pop-
ulation, however, that has been largely overlooked in
efforts to better understand the nonuse of ART is trans-
women. Transgender women experience a high burden
of HIV worldwide with pooled prevalence estimates at
19.1% (95% confidence interval [CI] 17.4–20.7).1 In
the United States, the burden of HIV for transgender
women may be even higher with average prevalence
rates among the highest of all risk groups.8–10
Because transwomen living with HIV (TWLH) can
be a very difficult population to access for research
studies, the few extant studies of TWLH are limited
in sample size and thus may have been lacking in ade-
quate power. Nonetheless, these studies remain valu-
able for their ability to inform intervention efforts.
For instance, a study of 35 TWLH assessed multi-
ple correlates of nonadherence to ART, for example,
depression, adherence self-efficacy, patient–provider
interactions, and perceived side effects.11 A study of
59 TWLH also assessed correlates of nonadherence,
for example, age, stress, transphobic experiences, and
hormone replacement therapy (HRT).12 A study of
113 TWLH found that recent psychosocial trauma
was associated with nonadherence to ART.13
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Given that nationally representative data suggest
greater proportions of TWLH not using ART than cis-
gender males living with HIV,14 it is important to have
a continued research focus designed to identify corre-
lates of this nonuse in TWLH. In particular, correlates
that may be amenable to change through counseling
have the opportunity to inform practice. Indeed, a pri-
mary research question that remains unexplored in the
published literature involves targeted counseling goals
for transgender women living with HIV, but not taking
ART. Counseling goals, by definition, must be amena-
ble to change at the individual-level.
Two general counseling goals for transwomen often
involve building resilience and improving satisfaction
with body image.15 Resilience is best conceptualized
as the primary protective factors against stress and
various forms of trauma.16,17 A recent study found ev-
idence suggesting that two forms of resilience (personal
competence, and acceptance of self and life) may be im-
portant outcomes of socially conferred gender affirma-
tion.18 Among transwomen, resilience may also be an
outgrowth of a favorable body image.19 A favorable
body image, in turn, may be a robust protective fac-
tor for transwomen, independently from resilience.20
Objectification theory provides a strong set of tenets
as to why body image is so often a vital aspect of the
self among transwomen.21,22
Accordingly, the purpose of the study was to test
three psychosocial measures for their potential to
serve as counseling goals in service of the larger goal
of using ART. The three measures were as follows:
(1) personal competence, (2) acceptance of self and
life, and (3) body image. We hypothesized that each
of these three constructs would be independently asso-
ciated with the outcome of ART use, after controlling
for variables that are not readily amenable to serve as
counseling goals. Specifically, we hypothesized that
TWLH having more favorable levels of each measure
would be more likely to adhere to ART use. In recog-
nition that these three measures would not be inde-
pendent, their respective influence was assessed using
multivariate regression.
Methods
Participants and procedures
Data were taken from a larger study (N = 161) of both
HIV-infected (N = 69) and HIV-uninfected (N = 92).
Multiple community-based outreach strategies were
used to recruit this community sample of transwomen
between ages 18 and 65 years, residing in Atlanta, Geor-
gia, or Chicago, Illinois. Venues serving transwomen
as well as word-of-mouth from transgender advocates
served as the primary methods for recruitment. In addi-
tion, the project was advertised through formal and in-
formal communication channels via advocacy groups
and lesbian, gay, bisexual, and transgender (LGBT) ser-
vice organizations. Also, recruiters approached trans-
women in the community and provided information
about the study. Word-of-mouth and flyers placed in
community venues serving transgender women were
also used. Print materials provided contact information
for the project coordinator. Data were collected from
October 2014 through June 2015 in Atlanta and from
April through October of 2017, in Chicago.
All participants were screened to determine eligibil-
ity. Requirements included the following: (1) being
18 to 65 years of age; (2) having been assigned male
at birth and self-identifying as either a transgender
woman, female, or gender-nonconforming identity;
and (3) reporting anal sex with a cisgender male or
nontransgender male in the past 6 months. After pro-
viding written informed consent, participants were
engaged in a face-to-face structured interview with a
trained graduate research assistant lasting *60–90min.
All interview survey responses were recorded on a
portable electronic tablet using Qualtricsª software
(Provo, UT). Self-report of HIV status as ‘‘positive’’
was used to classify the analytic subset for this study
(N = 69). The Institutional Review Boards for research
on human subjects at Georgia State University and the
University of Chicago approved all study protocols
and procedures.
Measures
For the outcome measure, a single-item assessed
whether TWLH were currently taking ART. For possi-
ble control variables, in addition to standard sociode-
mographic characteristics, we assessed several factors:
(1) current use of estrogen, (2) whether participants
had a legal name change to reflect their gender identity,
(3) whether participants were currently involved in
what they considered to be a committed relationship,
(4) whether participants had health insurance (includ-
ing Medicaid as an option) at the time of study enroll-
ment, and (5) an ordinal measure of placement in
terms of transitioning to a woman. This latter measure
was simply devised by our study team to reflect various
degrees of the transition process (not started, recently
started, somewhat transitioned, mostly transitioned,
and completely transitioned).
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For the predictor variables, three scale measures
were assessed as the factors of interest for this study
given our intent to identify potential counseling-
amenable targets for change that may best foster ART
use among those not taking advantage of this innova-
tion in HIV/AIDS care.
Personal competence. As a subscale of the Wagnild
and Young Resilience Scale,22 a six-item measure
was used to represent personal competence in manag-
ing daily life (Table 1). Response options included
a seven-point Likert scale, 1 = strongly disagree, 7=
strongly agree. Interitem reliability was excellent, with
a Cronbach’s alpha= 0.86.
Acceptance of self and life. Also, a subscale of the
Wagnild and Young Resilience Scale,22 a six-item mea-
sure was used to represent managing stress through
positive and proactive (Table 1). Response options in-
cluded a seven-point Likert scale (as above). Interitem
reliability was excellent, with a Cronbach’s alpha= 0.88.
Body image. A seven-item scale (created by the au-
thors) assessed body image. Interitem reliability was
excellent, with a Cronbach’s alpha= 0.83. Items were
prefaced with the question stem, ‘‘How happy are
you with.’’ and seven different words followed: face,
arms, chest, legs, feet, hair, and voice. Response options
were based on a five-point scale ranging from 1 (very
happy) to 5 (very unhappy).
Data analysis
First, bivariate associations between each possible con-
trol variable (Table 2) and the outcome of using ART
were assessed through either the use of chi-square
or t-tests, depending on the metric of measurement.
Using a screening value of p < 0.20, control variables
were then selected for use in a hierarchal logistic regres-
sion model. This model was constructed specifically to
test the study hypothesis, thus the three scale measures
were entered in a second block with the first block
being used only for direct entry of the selected control
variables. Significance for the model was defined by a
p-value of <0.05.
Results
Characteristics of the sample
The sample of 69 transgender women ranged from 19
to 65 years of age (mean = 34.9; standard deviation
[SD]= 10.9). Most (95.7%) identified as black or Afri-
can American. Slightly less than one-half of the sample
(44.9%) indicated receiving education beyond high
school. Current employment was indicated by 30.4%.
Table 1. Items Comprising the Two Subscales Derived
from the Wagnild & Young Measure of Resilience
Personal competence
I usually manage one way or another
I feel proud I have accomplished things in life
I am friends with myself
I have self-discipline
I can usually find something to laugh about
My life has meaning
Acceptance of self and life
Keeping interested in things is important to me
I usually take things in stride
I keep interested in things
I can usually look at a situation in a number of different ways
I am able to depend on myself more than anyone
I take things one day at a time
Table 2. Observed Bivariate Associations Between Possible
Control Variables and Nonuse of Antiretroviral Therapy
Among Transgender Women Living with HIV
Correlates tested
by Chi-square
% Not
taking ART
Chi-square
value p
City of recruitment
Atlanta (n = 50) 16.0 0.24 0.62
Chicago (n = 19) 21.1
Annual net income <$10,000
Yes (n = 45) 17.8 0.01 0.91
No (n = 24) 16.7
Current use of estrogen
Yes (n = 33) 6.1 5.65 0.017
No (n = 36) 21.1
Currently have health insurance
Yes (n = 41) 12.2 0.90 0.17
No (n = 28) 25.0
Had legal name change
Yes (n = 33) 12.1 1.22 0.27
No (n = 36) 22.2
Currently in a meaningful relationship
Yes (n = 29) 10.3 1.73 0.19
No (n = 40) 22.5
Correlates tested by t-tests
Mean if not
taking ART
Mean if
taking ART p
Age in years 26.9 36.5 0.005
Transition statusa 2.50 3.45 0.018
Personal Competence Scaleb 33.4 38.5 0.002
Acceptance of Self
and Life Scalec
34.5 38.1 0.03
Body Image Scaled 23.5 28.2 0.009
aThis was assessed on a five-point scale ranging from 1 =not begun to
5 = completed.
bScores ranged from 4 to 42, with higher scores representing greater
personal competence.
cScores ranged from 6 to 42, with higher scores representing greater
acceptance of self/life.
dScores ranged from 7 to 35, with higher scores representing greater
satisfaction w/body image.
ART, antiretroviral therapy.
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About two-thirds of the sample (65.2%) reported an
annual income (after taxes) of less than $10,000. Five
(7.2%) reported having sex with one or more biological
females in the past 6 months. The average number of
biological male sex partners in the past 6 months was
3.25 (SD = 6.55), with a range of 0 to 50 and a median
of 1.0. During this same 6-month recall period, the
mean number of male partners who engaged in anal
sex with participants was 3.05 (SD = 6.76), with a
range of 0 to 50. The mean number of male partners
who engaged in oral sex with participants was 2.65
(SD = 4.30), with a range of 0 to 25. About one-sixth
of the sample (15.4%) indicated that one or more of
the males they had sex with in the past 6 months was
a partner who gave money or drugs in exchange for
sex. Of the 69 TWLH, 17.4% were not taking ART.
Bivariate associations
Table 2 displays the observed bivariate associations. As
shown, three dichotomous correlates (health insurance,
use of estrogen, and a current meaningful relationship)
achieved the screening significance level of <0.20. Also
as shown, age, transition status, and each of the three
scale measures were well under the screening level of
bivariate significance.
Finally, we determined the correlations between the
three psychosocial measures. The measure of body
image was significantly correlated with the measure
of acceptance of self and life (r = 0.42). Furthermore,
body image was significantly correlated with the mea-
sure of personal competence (r = 0.45). Also, the mea-
sure of acceptance of self and life was significantly
correlated with perceived competence (r = 0.87).
Multivariate associations
Table 3 displays the adjusted odds ratios plus their 95%
CIs and p values relative to the variables retained in the
logistic regression model. As shown, only one achieved
multivariate significance: Personal Competence. Because
this was a continuous measure, assessed on a seven-
point scale, the protective adjusted odds ratio of 0.80
represents as 20% reduction in the odds of not taking
ART for each unit of increase in this construct.
Discussion
In an era of treatment as prevention being the dom-
inant approach to the control of HIV, this was an
important initial investigation pertaining to a highly
marginalized population, TWLH. Findings support the
strong association of a construct labeled personal com-
petence as a counseling goal for TWLH who are not
currently using ART. Specifically, counseling goals
related to helping TWLH gain an increased sense of
managing life, instilling self-discipline, finding mean-
ing in life and pride in their accomplishments, and
having a general sense of self-liking may all be valu-
able goals in terms of promoting their long-term use
of ART.
Notably, the vast majority of the sample identified as
black/African American. Fostering this type of resil-
ience may be especially important for this population
of TWLH given the historical significance of structural
and institutional racism that likely intersects with pov-
erty, sexism, and transphobia experienced by black
transgender women in the United States.23,24 Further-
more, the bivariate significance of the other two scales
tested (acceptance of self and life, and body image) sug-
gests that these factors may also be important in other
populations of TWLH. Whether, for instance, either
of these scales would be significant in a multivariate
model of a sample, including a lesser proportion of
black/African American TWLH is worthy of future
investigations.
In addition to the counseling implications, several
other practice-based implications are suggested by the
study findings. For example, current use of exogenous
estrogen was associated with a threefold decrease in
the odds of not taking ART. This observation raises
the possibility that providers of HRT to TWLH may
be, in parallel, promoting adherence of ART. Clearly,
HRT may be a strong driver for seeking health services
among transgender women, thus linking this service to
ART promotion/access is an important public health
practice. As a second example, the strong bivariate as-
sociation between transition status and ART use suggests
that TWLH who are less advanced in the transition-
ing process may be in greater need of intensified coun-
seling and outreach efforts designed to maintain the
Table 3. Adjusted Odds Ratios, 95% Confidence Intervals,
and p-Values of Variables Retained in the Logistic
Regression Model
Correlate
Adjusted
odds ratio 95% CI p
Age 0.96 0.86–1.07 0.42
Currently not taking estrogen 1.52 0.20–11.55 0.68
Currently have health insurance 0.14 0.02–1.06 0.06
Transition status 0.55 0.24–1.25 0.16
Currently not in a meaningful
relationship
0.57 0.08–3.97 0.58
Personal competence 0.80 0.67–0.97 0.02
CI, confidence interval.
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uptake of, and adherence to, ART. Finally, given the
small sample size, the near (i.e., p = 0.06) multivariate
significance of having health insurance is important
as it underscores the value of Medicaid and other
‘‘safety net’’ insurance programs for promoting ART
use and thus serving a primary goal of public health
in the era of HIV/AIDS.
Study findings provide a modest, yet novel, contribu-
tion to a growing body of empirical evidence relative
to HIV prevention and treatment for transgendered
women.24–28 This implication that a focus on building
personal competence may be a beneficial counseling
goal for transgender women coincides with rapidly
growing attention and investment in the HIV/AIDS
prevention, care, and treatment of this population.
The challenge, of course, in applying this implication
to practice is that counseling can only occur for trans-
gender women connected to care. We suggest, however,
that a ‘‘middle-ground’’ may exist in that posttest HIV
counseling, when HIV testing is done in nonclinical
settings, could be an opportune time to at least initiate a
counseling relationship with transgender women test-
ing reactive. Given a recent estimate from CDC that
more than 60% of U.S. transgender women have not
been tested for HIV,27 coupling community-based
HIV testing/counseling for those testing positive with
an interim avenue for ongoing counseling may help
promote their eventual uptake of, and adherence
to, ART.
Limitations
Many of the study participants were recruited through
referrals from community-based organizations pro-
viding services and support to transgender women.
Whether these women are representative of transgen-
der women not receiving similar support and services
is not known. Furthermore, the majority of our sample
identified as non-Hispanic black, thus the findings may
not generalize to other racial/ethnic populations of
TWLH. Also, that the two subscales derived from the
larger 25-item measure of resilience were constructed
and used in the same sample is a potential limitation.
Finally, the small sample size and corresponding lack
of adequate statistical power may have masked other-
wise significant and important study findings. We
clearly acknowledge that having only 12 of the 69
transwomen report not taking ART is a study limita-
tion. Had a larger proportion of the study participants
reported not taking ART, the available statistical power
would have increased thereby potentially giving two
variables a greater influence: having health insurance
and a current meaningful relationship.
Conclusion
This is one of the relatively larger community-based
studies of TWLH, a difficult to access population.
The findings suggest a potential counseling goal for
TWLH not taking ART. Community-based counseling
for transgender women recently testing positive for
HIV may benefit this population by seeking to help
them construct more favorable perceptions of their
personal competence. This goal may be achieved by
providing individualized counseling, tailored to meet
the needs of TWLH relative to the acquisition of en-
hanced personal competence.
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